Related Experiment Video
Updated: Jul 12, 2025

Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
Published on: June 3, 2018
Impact on Kidney Function and Medium-Term Outcomes of Transcatheter Aortic Valve Replacement in Patients With Chronic
Jwan A Naser1, Sushil Allen Luis1, Sorin V Pislaru1
1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Insights
Transcatheter aortic valve replacement (TAVR) outcomes in patients with chronic kidney disease (CKD) show that advanced CKD stages predict mortality beyond two years. Kidney function often improves post-TAVR.
Area of Science:
- Cardiology
- Nephrology
- Interventional Cardiology
Background:
- Transcatheter aortic valve replacement (TAVR) is a standard treatment for aortic stenosis.
- Long-term TAVR outcomes and their predictors in patients with chronic kidney disease (CKD) remain unclear.
- Understanding these outcomes is crucial for optimizing patient care.
Purpose of the Study:
- To assess medium-term TAVR outcomes in patients with varying stages of CKD.
- To develop a risk score for predicting 2-year mortality in CKD patients undergoing TAVR.
- To evaluate changes in kidney function following TAVR.
Main Methods:
- Retrospective analysis of adult patients who underwent TAVR.
- CKD staging determined using the CKD Epidemiology 2021 creatinine formula.
- Kidney function improvement defined by specific creatinine level changes post-TAVR.
Main Results:
- Higher all-cause mortality observed in CKD stages IV and V at a median follow-up of 2.9 years.
- Independent predictors of 2-year mortality included moderate/severe tricuspid regurgitation, anemia, elevated right ventricular systolic pressure, and advanced CKD stages (IV/V).
- At discharge, 6% experienced persistent acute kidney injury, while 12% showed improved kidney function.
Conclusions:
- CKD stage is an independent determinant of mortality beyond two years post-TAVR.
- A novel risk score can estimate 2-year mortality in TAVR patients with CKD.
- Kidney function is more likely to improve than worsen at hospital discharge after TAVR.
Abstract:
Transcatheter aortic valve replacement (TAVR) is now widely approved for the treatment of aortic stenosis, regardless of the patients' surgical risk. However, the outcomes of TAVR and their determinants in patients with chronic kidney disease (CKD) beyond 1 year of follow-up are unknown. We aimed to assess the medium-term outcomes of TAVR in CKD, develop a risk score to estimate the 2-year mortality in patients with CKD, and evaluate the changes in kidney function at discharge after TAVR. Adults who underwent TAVR were retrospectively identified. The CKD stage was determined using the Chronic Kidney Disease Epidemiology 2021 creatinine formula. Improved kidney function was defined as post-TAVR creatinine ≤50% of pre-TAVR creatinine or decrease in creatinine of ≥0.3 mg/100 ml compared with pre-TAVR creatinine. Overall, 1,523 patients (median age 82 years; 59% men; 735 with CKD stage II or less, 661 with CKD III, 83 with CKD IV, and 44 with CKD V [of whom 40 were on dialysis]) were included. The all-cause mortality was higher in CKD stages IV and V on the multivariable analysis (p <0.001) at median follow-up of 2.9 (interquartile range 2.0 to 4.2) years. Moderate or severe tricuspid regurgitation, anemia, right ventricular systolic pressure >40 mm Hg and CKD stages IV and V were independent predictors of 2-year mortality and were used to develop a risk score. At hospital discharge, persisting acute kidney injury after TAVR occurred in 88 of 1,466 patients (6%), whereas improved kidney function occurred in 170 of 1,466 patients (12%). In conclusion, CKD stage was an independent determinant of mortality beyond 2 years after TAVR. Kidney function was more likely to improve than worsen at the time of hospital discharge after TAVR.
Related Concept Videos
Kidney Transplant I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Cardiac Catheterization I: Pre-Procedure Overview
Kidney Transplant III: Nursing Management
Acute Kidney Injury II: Pathophysiology
Aortic Regurgitation III: Medical Management

